Alterity Therapeutics (ATHE) Operating Expenses (2015 - 2025)
Alterity Therapeutics' quarterly Operating Expenses came in at $4.3 million in Q4 2025, up 600.99% year-on-year from $617427.7 in Q4 2024, and up 600.99% quarter-over-quarter from -$863909.4 in Q4 2024.
Alterity Therapeutics has reported Operating Expenses for 10 years, with the latest figure at $4.3 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses rose 600.99% year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (down 24.95% YoY), and the FY2025 full-year result was $12.7 million, down 100.0% from the prior year.
- Operating Expenses for Q4 2025 stood at $4.3 million, up from -$863909.4 in the prior quarter.
- The five-year high for Operating Expenses was $5.5 million in Q4 2023, with the low at -$863909.4 in Q4 2024.
- Average Operating Expenses over 5 years is $3.4 million, with a median of $4.2 million recorded in 2022.
- Year-over-year, Operating Expenses plunged 115.77% in 2024 and soared 600.99% in 2025.
- Tracing ATHE's Operating Expenses over 5 years: stood at $4.1 million in 2021, then rose by 2.34% to $4.2 million in 2022, then surged by 31.26% to $5.5 million in 2023, then plunged by 115.77% to -$863909.4 in 2024, then soared by 600.99% to $4.3 million in 2025.
- The last three Operating Expenses figures came in at $4.3 million (Q4 2025), -$863909.4 (Q4 2024), and $5.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 445.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.33 Mn |
| Dec 31, 2024 | -863,909.37 |
| Dec 31, 2023 | 5.48 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Dec 31, 2021 | 4.08 Mn |
| Dec 31, 2019 | -5.10 Mn |
| Dec 31, 2018 | -5.63 Mn |
| Dec 31, 2017 | -3.21 Mn |
| Dec 31, 2016 | 4.47 Mn |
| Dec 31, 2015 | 4.11 Mn |